Abstract
We analyzed the clinicopathological characteristics of 1,425 primary breast cancer patients admitted to the Cancer Hospital of Shantou University Medical College from 1995 to 2008. The peak age group was 45-49 years old and median age was 49 years old. Sixty-two percent of the patients were pre-menopausal, while the remaining was postmenopausal. In the present study, 53% of the patients were in stage I-II of TNM staging. Immunohistochemical detection demonstrated that estrogen receptor (ER), progestrone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) were 59%, 56% and 32% positive, respectively. The most common histological type was invasive ductal carcinoma accounting for 76% of total patients. Most patients received surgical treatment (97.2%) and chemotherapy (74.4%). The overall five-year and ten-year survival rates were 63% and 56% respectively. Multivariate analyses revealed that the tumor size, axillary lymph node involvement, and clinical staging were independent risk factors for overall survival (OS). In summary, the largest cohort of breast cancer patients in Eastern Guangdong was analyzed with their clinicopathological characteristics. We demonstrated that the similar clinical outcomes were obtained by multi-modality therapy, and the tumor size and lymph node involvement are the independent prognostic factors being same as the previous reports.
Keywords: Breast cancer, clinicopathological characteristics, lymph node involvement, overall survival, prognosis, tumor size.
Current Signal Transduction Therapy
Title:Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China
Volume: 9 Issue: 1
Author(s): Wen-He Huang, Si-Qi Qiu, Jun-Dong Wu, Cai-Wen Du, Yu-Kun Cui and Guo-Jun Zhang
Affiliation:
Keywords: Breast cancer, clinicopathological characteristics, lymph node involvement, overall survival, prognosis, tumor size.
Abstract: We analyzed the clinicopathological characteristics of 1,425 primary breast cancer patients admitted to the Cancer Hospital of Shantou University Medical College from 1995 to 2008. The peak age group was 45-49 years old and median age was 49 years old. Sixty-two percent of the patients were pre-menopausal, while the remaining was postmenopausal. In the present study, 53% of the patients were in stage I-II of TNM staging. Immunohistochemical detection demonstrated that estrogen receptor (ER), progestrone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) were 59%, 56% and 32% positive, respectively. The most common histological type was invasive ductal carcinoma accounting for 76% of total patients. Most patients received surgical treatment (97.2%) and chemotherapy (74.4%). The overall five-year and ten-year survival rates were 63% and 56% respectively. Multivariate analyses revealed that the tumor size, axillary lymph node involvement, and clinical staging were independent risk factors for overall survival (OS). In summary, the largest cohort of breast cancer patients in Eastern Guangdong was analyzed with their clinicopathological characteristics. We demonstrated that the similar clinical outcomes were obtained by multi-modality therapy, and the tumor size and lymph node involvement are the independent prognostic factors being same as the previous reports.
Export Options
About this article
Cite this article as:
Huang Wen-He, Qiu Si-Qi, Wu Jun-Dong, Du Cai-Wen, Cui Yu-Kun and Zhang Guo-Jun, Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China, Current Signal Transduction Therapy 2014; 9 (1) . https://dx.doi.org/10.2174/1574362409666140724183612
DOI https://dx.doi.org/10.2174/1574362409666140724183612 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX™ and Tailored Delivery to the Gut
Current Medicinal Chemistry Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design Aromatase, Estrogens and Testicular Germ Cell Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status
Current Respiratory Medicine Reviews Subject Index Volume 2
Medicinal Chemistry Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
Reviews on Recent Clinical Trials Strategies for Development of Antimalarials Based on Encapsulated Porphyrin Derivatives
Mini-Reviews in Medicinal Chemistry The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Implication of Aberrant Glycosylation in Cancer and Use of Lectin for Cancer Biomarker Discovery
Protein & Peptide Letters Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
Recent Patents on Anti-Cancer Drug Discovery Design of Ru-arene Complexes for Antitumor Drugs
Mini-Reviews in Medicinal Chemistry In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha
Current Computer-Aided Drug Design The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenomics of Arylamine N-acetyltransferase
Current Pharmacogenomics Cascade Reaction in the Synthesis of Heterocyclic Natural Products
Current Organic Chemistry Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates
Current Cancer Drug Targets HER2-Mediated Anticancer Drug Delivery: Strategies to Prepare Targeting Ligands Highly Specific for the Receptor
Current Medicinal Chemistry Neuronal Death in Amyotrophic Lateral Sclerosis (ALS): What Can We Learn from Genetics?
CNS & Neurological Disorders - Drug Targets